Oxford, United Kingdom

Geoffrey L Smith

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2002-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Geoffrey L Smith

Introduction

Geoffrey L Smith is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of immunization, holding a total of 8 patents. His work focuses on developing methods and reagents that enhance immune responses, particularly against malarial and other antigens.

Latest Patents

Smith's latest patents include innovative methods and reagents for immunization that generate a CD8 T cell immune response. These patents describe new vaccination methods that utilize a priming composition and a boosting composition. The boosting composition comprises a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope, which is also present in the priming composition. This approach aims to improve the efficacy of vaccines against various diseases, including malaria, viral infections, and tumors.

Career Highlights

Throughout his career, Geoffrey L Smith has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Oxxon Therapeutics Limited. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Some of his notable coworkers include Bernard Moss and Michael Mackett. Their collaboration has likely played a role in the development of innovative solutions in the field of immunology.

Conclusion

Geoffrey L Smith's contributions to immunization and vaccine development are noteworthy, with a focus on generating effective immune responses. His patents and collaborations reflect his commitment to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…